Tocilizumab for refractory systemic juvenile idiopathic arthritis

Objective: To evaluate the efficacy and side effects of tocilizumab for the treatment of systemic juvenile idiopathic arthritis. Method: In this prospective self case-control study, the children diagnosed with refractory systemic juvenile idiopathic arthritis admitted to Department of Rheumatism and...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Zhonghua er ke za zhi = Chinese journal of pediatrics. - 1960. - 55(2017), 11 vom: 02. Nov., Seite 830-834
1. Verfasser:	Lai, J M (VerfasserIn)
Weitere Verfasser:	Wu, F Q, Zhou, Z X, Kang, M, Huang, X L, Su, G X, Li, S N, Zhu, J, Wang, X N
Format:	Online-Aufsatz
Sprache:	Chinese
Veröffentlicht:	2017
Zugriff auf das übergeordnete Werk:	Zhonghua er ke za zhi = Chinese journal of pediatrics
Schlagworte:	Journal Article Arthritis, juvenile rheumatoid Tocilizumab Treatment outcome Antibodies, Monoclonal, Humanized IL6 protein, human Interleukin-6 Tumor Necrosis Factor-alpha C-Reactive Protein 9007-41-4 mehr... tocilizumab I031V2H011